vs

Side-by-side financial comparison of Enlight Renewable Energy Ltd. (ENLT) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($204.6M vs $109.5M, roughly 1.9× Enlight Renewable Energy Ltd.).

Enlight Renewable Energy is a publicly traded company, headquartered in Israel, that builds and operates solar and wind power facilities. Its shares are traded on the Tel Aviv Stock Exchange and on Nasdaq (ENLT) following the company’s United States initial public offering in February 2023. In addition to solar and wind, Enlight develops utility-scale energy storage and agrivoltaic projects integrating agricultural land use with photovoltaic generation.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

ENLT vs INSP — Head-to-Head

Bigger by revenue
INSP
INSP
1.9× larger
INSP
$204.6M
$109.5M
ENLT

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ENLT
ENLT
INSP
INSP
Revenue
$109.5M
$204.6M
Net Profit
Gross Margin
86.5%
Operating Margin
60.1%
13.0%
Net Margin
Revenue YoY
1.6%
Net Profit YoY
EPS (diluted)
$123305879.00
$-0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENLT
ENLT
INSP
INSP
Q1 26
$204.6M
Q4 25
$109.5M
$269.1M
Q3 25
$224.5M
Q2 25
$84.7M
$217.1M
Q1 25
$90.4M
$201.3M
Q4 24
$73.8M
$239.7M
Q3 24
$58.3M
$203.2M
Q2 24
$52.6M
$195.9M
Net Profit
ENLT
ENLT
INSP
INSP
Q1 26
Q4 25
$136.1M
Q3 25
$9.9M
Q2 25
$-3.6M
Q1 25
$3.0M
Q4 24
$35.2M
Q3 24
$18.5M
Q2 24
$9.8M
Gross Margin
ENLT
ENLT
INSP
INSP
Q1 26
86.5%
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
48.9%
84.1%
Q2 24
55.5%
84.8%
Operating Margin
ENLT
ENLT
INSP
INSP
Q1 26
13.0%
Q4 25
60.1%
17.1%
Q3 25
4.3%
Q2 25
41.2%
-1.5%
Q1 25
47.4%
-0.7%
Q4 24
58.1%
13.3%
Q3 24
73.2%
7.0%
Q2 24
63.7%
2.6%
Net Margin
ENLT
ENLT
INSP
INSP
Q1 26
Q4 25
50.6%
Q3 25
4.4%
Q2 25
-1.7%
Q1 25
1.5%
Q4 24
14.7%
Q3 24
9.1%
Q2 24
5.0%
EPS (diluted)
ENLT
ENLT
INSP
INSP
Q1 26
$-0.39
Q4 25
$123305879.00
$4.57
Q3 25
$0.34
Q2 25
$125866004.00
$-0.12
Q1 25
$122889909.00
$0.10
Q4 24
$1.17
Q3 24
$125866004.00
$0.60
Q2 24
$125873060.00
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENLT
ENLT
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$98.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$792.3M
Total Assets
$911.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENLT
ENLT
INSP
INSP
Q1 26
$98.9M
Q4 25
$308.3M
Q3 25
$322.6M
Q2 25
$300.9M
Q1 25
$369.2M
Q4 24
$387.4M
$445.5M
Q3 24
$411.0M
Q2 24
$439.7M
Stockholders' Equity
ENLT
ENLT
INSP
INSP
Q1 26
$792.3M
Q4 25
$781.2M
Q3 25
$666.5M
Q2 25
$677.8M
Q1 25
$635.7M
Q4 24
$1.4B
$689.7M
Q3 24
$696.6M
Q2 24
$638.1M
Total Assets
ENLT
ENLT
INSP
INSP
Q1 26
$911.4M
Q4 25
$907.3M
Q3 25
$807.7M
Q2 25
$802.2M
Q1 25
$730.8M
Q4 24
$5.5B
$808.4M
Q3 24
$796.2M
Q2 24
$728.4M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENLT
ENLT

Segment adjusted EBITDA$99.7M91%
Tax benefits$10.1M9%

INSP
INSP

Segment breakdown not available.

Related Comparisons